Qurled 400 mg (Sofosbuvir) is an anti-viral drug indicated against chronic hepatitis C (HCV) infection with genotype 1-4. Sofosbuvir is known for its direct-acting antiviral (DAA) properties inhibiting non-structural protein 5B (NS5B) protein, a special type of protein responsible for multiplication (RNA replication and virion assembly) of viral cells.
For achieving a sustained virologic response (SVR), sofosbuvir is used with other anti-HCV agents assisting in,
- Reduction of damages associated with liver
- Improvement in the quality of life of patients
- Liver cancer incidence
Administration of Qurled 400 mg (Sofosbuvir):
Qurled 400 mg (Sofosbuvir) is administered orally once in a form of 400 mg dose taken with or without food. In addition, either ribavirin alone or ribavirin plus pegylated interferon is also recommended.
Table: Dosage regimen for Qurled 400 mg (Sofosbuvir)
Type of HCV patients | Recommended dosage | Duration (weeks) |
Genotype 1 or 4 | Qurled 400 mg (Sofosbuvir) plus ribavirin and pegylated interferon | 12 |
Genotype 2 | Qurled 400 mg (Sofosbuvir) plus ribavirin | |
Genotype 3 | Qurled 400 mg (Sofosbuvir) plus ribavirin | 24 |
Modified duration in special conditions | ||
Unable to take the interferon-based regimen (Genotype 1) | Qurled 400 mg (Sofosbuvir) and ribavirin | 24 instead of 12 |
Have liver cancer and waiting for their liver transplantation | 48 or until the day of transplantation |
Note: Both pros and cons should be taken into consideration before increasing the duration of treatment.
Once swallowed, sofosbuvir is absorbed (bio-available) in between 30 mins to 2 hours with a binding affinity of 61-65% with viral cells. It is generally metabolized in the liver and after its activities, more than 50% of the drug is excreted from the body in between 40 minutes to 27 hours.
When should Hepcinat 400 (Sofosbuvir) be avoided or used cautiously?
Interactions with other drugs:
If patients were taking other drugs before or along with sofosbuvir,
- The efficacy gets comprised
- Dosages need to be modified
- Shows a higher rate of side-effects
Other warning signs:
If patients are suffering from or had,
- History of Hepatitis B viral infection before taking sofosbuvir.
- Liver transplant before the initiation of dosage
- Complications in the liver other than HCV infection
- Heart problems
- Kidney disease or undergoing dialysis
- HIV infection
- Other severe medical condition
Issues during child-birth if patients,
- Are pregnant or planning to get pregnant
- Are male and your partner is planning to get pregnant
- Are breastfeeding or planning to breastfeed
Side-effects of Qurled 400 mg (Sofosbuvir):
Sofosbuvir has a reasonable safety profile with minimal side-effects. Due to its safety profile, it has a therapeutic advantage over other anti-HCV agents like the absence of low red blood cell (RBC) count (anemia) and neuropsychiatric effects.
Serious side-effects: Slow heart rate (bradycardia)
Side-effects in combination with ribavirin:
- Headache
- Tiredness (Fatigue)
Side-effects in combination with ribavirin and pegylated interferon:
- Lack of sleep (Insomnia)
- Nausea
- Tiredness (Fatigue)
- Headache
Uncommon side-effects:
- Pain in the muscles (Myalgia)
- Physical weakness (Asthenia)
- Skin itchiness (Pruritis)
- Diarrhea
- Severe rashes on the skin
- Fever
- Chills
- Low consumption of diet
Note: These are not all possible side-effects of Qurdac 400 mg (Sofosbuvir), please ask your doctor for more information regarding the same.
Reviews
There are no reviews yet.